That's why we're thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).
Directory
Susan Mallery
Chair, Division of Oral and Maxillofacial Pathology and Radiology | DDS, PhD | Columbus, OH
Research interests include chemoprevention of oral cancer by natural products, using a continuum of experimental designs that range from cell and animal models to human clinical trials to provide mechanistic insights and determine chemopreventive efficacy, with a focus on controlled-release, local delivery methods.
FA Research Projects
The Latest
News & Events
In 1989, Lynn and David Frohnmayer founded the Fanconi Anemia Research Fund (FARF), determined and desperate to find a cure for their three daughters diagnosed with Fanconi anemia (FA). Since then, their vision has grown into a vibrant community of FA families, researchers, clinicians, donors, fundraisers, staff, and volunteers, all dedicated to improving outcomes for people with FA.
Research is the answer to one day making FA a treatable, manageable disease. Here, you'll discover the most recent strides in FA research and activities funded by FCF. Every quarter, we'll bring you updates on newly funded grants, ongoing projects, and significant milestones.